Stockscreener 앱 받기
1.49
2.76%
0.04
시장 영업 전:
1.45
-0.04
-2.68%
전일 마감가:
$1.45
열려 있는:
$1.37
하루 거래량:
113.35K
Relative Volume:
0.23
시가총액:
$1.29M
수익:
-
순이익/손실:
$-5.02M
주가수익비율:
-0.1755
EPS:
-8.4895
순현금흐름:
$-3.96M
1주 성능:
-5.70%
1개월 성능:
-40.16%
6개월 성능:
-65.55%
1년 성능:
-84.72%
1일 변동 폭
$1.34
$1.53
1주일 범위
$1.28
$1.61
52주 변동 폭
$1.28
$17.95
패인리폼 Stock (PRFX) Company Profile
명칭
Prf Technologies Ltd
전화
-
주소
-
Compare PRFX vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRFX
Prf Technologies Ltd
|
1.49 | 1.26M | 0 | -5.02M | -3.96M | -8.4895 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
패인리폼 주식(PRFX)의 최신 뉴스
PRFX Q2 2024 Earnings: EPS Misses Estimates as Company Continues Development StageEarnings Revision Upgrade - Newser
$PRF Technologies (PRFX.US)$ Blacklist this lousy stock - Moomoo
[EFFECT] PRF Technologies Ltd. SEC Filing - Stock Titan
PRF Technologies (PRFX) registers 3,000,000 shares; $10M equity facility - Stock Titan
PRFX: Share Offering by Selling Stockholder Announced - GuruFocus
PRF Technologies (PRFX) registers 3.0M shares for resale under equity line - Stock Titan
YA II PN's 9.99% PRFX position and $10M SEPA with PRF Technologies (PRFX) - Stock Titan
PRF Technologies Secures Up to $10 Million Standby Equity Facility With Yorkville - The Globe and Mail
What PRF Technologies (PRFX) is doing that smarter investors notice (-0.52%) 2026-05-07Stock Picks - Newser
PRF Technologies (NASDAQ: PRFX) inks $10M standby equity deal with Yorkville - Stock Titan
EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain - Yahoo Finance
PRF Technologies Wins FDA IND Clearance for OcuRing-K Phase II Cataract Trial - The Globe and Mail
FDA clears PRF Technologies’ IND for cataract surgery treatment - Investing.com UK
FDA clears PRF Technologies’ IND for cataract surgery treatment By Investing.com - Investing.com South Africa
PRFX Receives FDA Clearance for OcuRing-K Clinical Trials - GuruFocus
FDA clears PRF Technologies (PRFX) IND for OcuRing-K Phase II eye trial - Stock Titan
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial - The Manila Times
PRF Technologies Ltd. Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial - marketscreener.com
PRF Technologies Ltd. Ordinary Shares (PRFX) posts far wider Q1 2024 loss than analyst estimates, sending its shares down 2.18% today.Customer Loyalty - Cổng thông tin điện tử tỉnh Tây Ninh
PRFX (PRF Technologies Ltd. Ordinary Shares) reports far wider Q1 2024 loss than estimates, shares dip modestly today.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh
PRF Technologies (PRFX) Stock Manual Trade (Momentum Fading) 2026-04-20Trending Stock Ideas - Newser
Ellen S Baron Net Worth (2026) - GuruFocus
Sigal Aviel Net Worth (2026) - GuruFocus
Ehud Geller Net Worth (2026) - GuruFocus
Eyal Broder Net Worth (2026) - GuruFocus
Efraim Cohen Arazi Net Worth (2026) - GuruFocus
Asaf Shavit Net Worth (2026) - GuruFocus
PRF Technologies (PRFX) Stock: Valuation Perspective (-2.18%) 2026-04-15Expert Breakout Alerts - UBND thành phố Hải Phòng
What's Going On With Pharma Company PRF Technologies On Tuesday? - Sahm
Morning Market Movers: ADVB, SKYQ, FCUV, KPRX See Big Swings - RTTNews
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
12 Health Care Stocks Moving In Monday's Intraday SessionABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ - Benzinga
PRF Technologies Sees Strategic Growth with DeepSolar Expansion - StocksToTrade
PRF Technologies Expands Global Solar Reach: Strategic Partnership with Blade Ranger - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$PRF Technologies (PRFX.US)$ 🫡 out .91 - Moomoo
Is PRF Technologies (PRFX) Stock Breaking Resistance | Price at $2.63, Up 25.24%Investment Factor - Newser
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
PRFX SEC FilingsPRF Technologies Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
PRFX Should I Buy - Intellectia AI
PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot - The Globe and Mail
PRF Technologies reports 2025 results, advances drug delivery platform By Investing.com - Investing.com Australia
PRF Technologies reports 2025 results, advances drug delivery platform - Investing.com
[6-K] PRF Technologies Ltd. Current Report (Foreign Issuer) | PRFX SEC FilingForm 6-K - Stock Titan
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across ... - Bluefield Daily Telegraph
PRF Technologies Provides Year-End 2025 Business Update - GlobeNewswire
PRF Technologies (NASDAQ: PRFX) 20-F details going concern risk and cash needs - Stock Titan
패인리폼 (PRFX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.92%
4.44%
자본화:
|
볼륨(24시간):